Somapacitan
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB15093 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 8 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | allergic asthma | KG + DL |
| 2 | intrinsic asthma | KG + DL |
| 3 | brain small vessel disease 1 with or without ocular anomalies | KG + DL |
| 4 | autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome | KG + DL |
| 5 | renin-angiotensin-aldosterone system-blocker-induced angioedema | KG + DL |
| 6 | gout | KG + DL |
| 7 | autoimmune hemolytic anemia | KG + DL |
| 8 | diabetic nephropathy | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.